Crossmark

Alliance A091103 a phase II study of the angiopoietin 1 and 2 peptibody trebananib for the treatment of angiosarcoma

Crossref DOI link: https://doi.org/10.1007/s00280-015-2689-8

Published Online: 2015-02-12

Published Print: 2015-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

D’ Angelo, Sandra P.

Mahoney, Michelle R.

Van Tine, Brian A.

Adkins, Douglas R.

Perdekamp, Maria T. Grosse

Condy, Mercedes M.

Luke, Jason J.

Hartley, Eliza Woodward

Antonescu, Cristina R.

Tap, William D.

Schwartz, Gary K.
License Information

Text and Data Mining valid from 2015-02-12